抗CD22（pinatuzumab biosimilar）单克隆抗体,Anti-CD22 (pinatuzumab biosimilar) monoclonal antibody 生命科学产品与技术服务-生工生物工程(上海)股份有限公司

Order NO. D146054

抗CD22（pinatuzumab biosimilar）单克隆抗体

英文名	Anti-CD22 (pinatuzumab biosimilar) monoclonal antibody
别名	CD22; ACD22-VCMMAE; DCDT2980S; FCU2803; RG-7593; RO5541072-000
相关类别	IVD抗体原料	储存	冷冻（-20℃）
宿主	Humanized	反应种属	Human
标记物	Unconjugate	克隆类型	monoclonal
抗原	CD22
在线咨询

属性

Background:	Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.
Applications:	ELISA, FC
Name of antibody:	CD22
Common name:	ACD22-VCMMAE, DCDT2980S, FCU2803, RG-7593, RO5541072-000
Synonyms:	CD22;SIGLEC2;BL-CAM;SIGLEC-2;Siglec2;SIGLEC2FLJ22814
SwissProt:	P20273
ELISA Recommended dilution:	5000-10000
FC Recommended dilution:	50-100

相关文档

Sample Application

ELISA plate pre-coated by 2 μg/ml (100 μL/well) Human CD22, hFc-His tagged protein (Catalog number: D145009) can bind Anti-CD22 monoclonal antibody (Catalog number: D146054) in a linear range of 3.2-400 ng/ml. In order to specifically detect D146054, mouse anti-human Fab-specific antibody was used as detection antibody.
HEK293 cell line transfected with human CD22 and irrelevant protein were surface stained with Anti-CD22 monoclonal antibody (Catalog number: D146054) 1 μg/ml followed by Alexa 488-conjugated anti-human IgG secondary antibody.